# Use of Apheretic Technologies in Cardiovascular Disease

> **NCT02380534** · NA · WITHDRAWN · sponsor: **University of Pavia**

## Conditions studied

- Dyslipidemia

## Interventions

- **PROCEDURE:** H.E.L.P. apheresis

## Key facts

- **NCT ID:** NCT02380534
- **Lead sponsor:** University of Pavia
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** —
- **Primary completion:** 2016-02-04
- **Final completion:** —
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Funding missing
- **Last updated:** 2022-05-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02380534

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02380534, "Use of Apheretic Technologies in Cardiovascular Disease". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02380534. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*